Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 6, 2024World Journal of OncologyOpen Access

Accumulation of CD56+ CD16- Natural Killer Cells in Response to Preoperative Chemotherapy for Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

RKRyungsa KimHiroshima UniversityAKAmi KawaiHiroshima UniversityMWMegumi WakisakaHiroshima University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kim et al. (2024) studied this question.

synapsesocial.com/papers/68e6129eb6db6435875a5ae8https://doi.org/10.14740/wjon1885
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Human natural killer cells: their origin, receptors and function2002 · 240 citations
  2. 2Treatment response and 5-year distant metastasis-free survival outcome in breast cancer patients after the use of MammaPrint and BluePrint to guide preoperative systemic treatment decisions2022 · 14 citations
  3. 3CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation2011 · 152 citations
  4. 4Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer2019 · 156 citations
  5. 5Why natural killer cells in triple negative breast cancer?2020 · 56 citations